TABLE 2.
Variables | Univariate Analysis | Multivariate Analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
β | S.E | Z | P | OR (95%CI) | β | S.E | Z | P | OR (95%CI) | |
Date of iNO Initiation≤168 h (7 d) | −2.38 | 1.38 | 2.15 | 0.032 | 0.09 (0.01–0.81) | −3.16 | 1.45 | 2.18 | 0.043 | 0.06 (0.00–0.92) |
Initial iNO Dose (ppm)) | −0.15 | 0.05 | −3.15 | 0.002 | 0.86 (0.79–0.95) | −0.39 | 0.15 | −2.67 | 0.008 | 0.68 (0.51–0.90) |
Duration of iNO Therapy (hours) | 0.00 | 0.00 | 1.14 | 0.253 | 1.00 (1.00–1.01) | −0.00 | 0.00 | −0.54 | 0.588 | 1.00 (0.99–1.00) |
Maximum iNO Dose (ppm) | −0.08 | 0.04 | −2.01 | 0.044 | 0.92 (0.85–0.99) | 0.24 | 0.14 | 1.71 | 0.087 | 1.28 (0.96–1.69) |
The bold values indicate statistically significant results (p < 0.05).
OR, Odds Ratio; CI, Confidence Interval.